Clearline Capital LP Cytom X Therapeutics, Inc. Transaction History

Clearline Capital LP

  • $2.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.53 - $2.89 $9,153 - $17,290
5,983 Added 3.14%
196,583 $360,000
Q1 2022

May 16, 2022
BUY
$2.67 - $4.68 $121,752 - $213,408
45,600 Added 31.45%
190,600 $509,000
Q4 2021

Feb 14, 2022
BUY
$3.87 - $7.39 $561,150 - $1.07 Million
145,000 New
145,000 $628,000

Others Institutions Holding CTMX

# of Institutions
68
Shares Held
50.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $66M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email